LINC01094 and breast cancer: However, they have been demonstrated to be dysregulated extensively in human malignancies, and they control essential metabolic regulatory networks by directly binding to one or more protein partners.[41] To explore the molecular regulatory mechanism of LINC01094 in BC, we employed comprehensive identification of RBPs by RNA pull‐down assay to authenticate the composition and dynamics of ad hoc binding of RBP complexes with LINC01094.